No Data
Apichope pharmaceutical (300723.SZ): The Fenobide choline sustained-release capsule has been included in the national medical insurance catalog.
On November 28, Gelonghui reported that apichope pharmaceutical (300723.SZ) announced, according to the notice issued by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security regarding the "National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Pharmaceutical Catalog (2024)" (医保发[2024]33号, hereinafter referred to as the "2024 National Medical Insurance Catalog"), the product cholestyramine phenolic capsules from the company's wholly-owned subsidiary Guangzhou Lianrui Pharmaceutical Co., Ltd. has been included in the "2024 National Medical Insurance Catalog" for the first time after negotiations.
The 8.3% Return This Week Takes ApicHope Pharmaceutical's (SZSE:300723) Shareholders Five-year Gains to 77%
ApicHope Pharmaceutical's Unit Gets Green Light to Trial Influenza Vaccine; Shares Up 6%
apichope pharmaceutical (300723.SZ): The quadrivalent recombinant protein vaccine of South China Vaccines has obtained clinical trial approval.
Gelonghui November 6th|apichope pharmaceutical (300723.SZ) announced that recently, the pharmaceutical clinical trial application of the four-valent influenza recombinant protein vaccine independently developed by Guangdong Huainan Vaccine Co., Ltd., a subsidiary controlled by apichope pharmaceutical, has been approved by the National Pharmaceutical Regulatory Authority, and has received the "Drug Clinical Trial Approval Notice" (Notice No.: 2024LP02496), allowing clinical trials for the prevention of influenza. The four-valent influenza recombinant protein vaccine that obtained the clinical trial application this time can stimulate the body to produce antibodies against the four-valent influenza virus.
Private Companies Invested in ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Copped the Brunt of Last Week's CN¥454m Market Cap Decline
Poinsettia: Report for the third quarter of 2024
Do ApicHope Pharmaceutical's (SZSE:300723) Earnings Warrant Your Attention?No Data
No Data
